Changes in platelet morphology and function during 24 hours of storage

被引:33
作者
Braune, S. [1 ,2 ,3 ]
Walter, M. [1 ,2 ,3 ]
Schulze, F. [1 ,2 ]
Lendlein, A. [1 ,2 ,3 ]
Jung, F. [1 ,2 ]
机构
[1] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany
[2] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany
[3] Univ Potsdam, Inst Chem, Potsdam, Germany
关键词
Platelet; platelet function; platelet rich plasma; whole blood; platelet aging; platelet storage; hemocompatibility; biomaterials; FUNCTION ANALYZER; BLEEDING-TIME; BLOOD; MICROPARTICLES; PLATELET-FACTOR-4; HEMOSTASIS; COLLECTION; ACTIVATION; STANDARDS; RELEASE;
D O I
10.3233/CH-141876
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
For in vitro studies assessing the interaction of platelets with implant materials, common and standardized protocols for the preparation of platelet rich plasma (PRP) are lacking, which may lead to non-matching results due to the diversity of applied protocols. Particularly, the aging of platelets during prolonged preparation and storage times is discussed to lead to an underestimation of the material thrombogenicity. Here, we study the influence of whole blood-and PRP-storage times on changes in platelet morphology and function. Blood from apparently healthy subjects was collected according to a standardized protocol and examined immediately after blood collection, four hours and twenty four hours later. The capability of platelets to adhere and form stable aggregates (PFA100, closure time) was examined in sodium citrate anticoagulated whole blood (WB) using the agonists equine type I collagen and epinephrine bitartrate (collagen/epinephrine) as well as equine type I collagen and adenosine-5'-diphosphate (collagen/ADP). Circulating platelets were quantified at each time point. Morphology of platelets and platelet aggregates were visualized microscopically and measured using an electric field multi-channel counting system (CASY). The percentage of activated platelets was assessed by means of P-selectin (CD62P) expression of circulating platelets. Furthermore, platelet factor 4 (PF4) release was measured in platelet poor plasma (PPP) at each time point. Whole blood PFA100 closure times increased after stimulation with collagen/ADP and collagen/epinephrine. Twenty four hours after blood collection, both parameters were prolonged pathologically above the upper limit of the reference range. Numbers of circulating platelets, measured in PRP, decreased after four hours, but no longer after twenty four hours. Mean platelet volumes (MPV) and platelet large cell ratios (P-LCR, 12 fL - 40 fL) decreased over time. Immediately after blood collection, no debris or platelet aggregates could be visualized microscopically. After four hours, first debris and very small aggregates occurred. After 24 hours, platelet aggregates and also debris progressively increased. In accordance to this, the CASY system revealed an increase of platelet aggregates (up to 90 mu m diameter)with increasing storage time. The percentage of CD62P positive platelets and PF4 increased significantly with storage time in resting PRP. When soluble ADP was added to stored PRP samples, the number of activatable platelets decreased significantly over storage time. The present study reveals the importance of a consequent standardization in the preparation of WB and PRP. Platelet morphology and function, particularly platelet reactivity to adherent or soluble agonists in their surrounding milieu, changed rapidly outside the vascular system. This knowledge is of crucial interest, particularly in the field of biomaterial development for cardiovascular applications, and may help to define common standards in the in vitro hemocompatibility testing of biomaterials.
引用
收藏
页码:159 / 170
页数:12
相关论文
共 45 条
[1]
[Anonymous], 1981, REFERENCE VALUES LAB
[2]
BACH R, 1994, THROMB RES, V74, pS55
[3]
Are there sufficient standards for the in vitro hemocompatibility testing of biomaterials? [J].
Braune, Steffen ;
Grunze, Michael ;
Straub, Andreas ;
Jung, Friedrich .
BIOINTERPHASES, 2013, 8 :1-9
[4]
Dynamic in vitro hemocompatibility testing of poly(ether imide) membranes functionalized with linear, methylated oligoglycerol and oligo(ethylene glycol) [J].
Braune, Steffen ;
von Ruesten-Lange, Maik ;
Mrowietz, Christof ;
Luetzow, Karola ;
Roch, Toralf ;
Neffe, Axel T. ;
Lendlein, Andreas ;
Jung, Friedrich .
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2013, 54 (03) :235-248
[5]
THE MEGAKARYOCYTE PLATELET SYSTEM AND VASCULAR-DISEASE [J].
BROWN, AS ;
MARTIN, JF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 :9-15
[6]
INTERACTION OF PLATELET FACTOR-4 WITH HUMAN-PLATELETS [J].
CAPITANIO, AM ;
NIEWIAROWSKI, S ;
RUCINSKI, B ;
TUSZYNSKI, GP ;
CIERNIEWSKI, CS ;
HERSHOCK, D ;
KORNECKI, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 839 (02) :161-173
[7]
Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH [J].
Cattaneo, M. ;
Cerletti, C. ;
Harrison, P. ;
Hayward, C. P. M. ;
Kenny, D. ;
Nugent, D. ;
Nurden, P. ;
Rao, A. K. ;
Schmaier, A. H. ;
Watson, S. P. ;
Lussana, F. ;
Pugliano, M. T. ;
Michelson, A. D. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (06) :1183-1189
[8]
The Platelet Storage Lesion [J].
Devine, Dana V. ;
Serrano, Katherine .
CLINICS IN LABORATORY MEDICINE, 2010, 30 (02) :475-+
[9]
High-resolution CryoFESEM of individual cell adhesion molecules (CAMs) in the glycocalyx of human platelets:: Detection of P-selectin (CD62P), GPI-IX complex (CD42a/CD42bα,bβ), and integrin GPIIbIIIa (CD41/CD61) by immunogold labeling and stereo imaging [J].
Erlandsen, SL ;
Bittermann, AG ;
White, J ;
Leith, A ;
Marko, M .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (07) :809-819
[10]
Contemporary platelet function testing [J].
Favaloro, Emmanuel J. ;
Lippi, Giuseppe ;
Franchini, Massimo .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (05) :579-598